Saul A - Search Results

1

Formulation of vaccines containing CpG oligonucleotides and alum.

Aebig JA, Mullen GE, Dobrescu G, Rausch K, Lambert L, Ajose-Popoola O, Long CA, Saul A, Miles AP. Aebig JA, et al. Among authors: saul a. J Immunol Methods. 2007 Jun 30;323(2):139-46. doi: 10.1016/j.jim.2007.04.003. Epub 2007 May 11. J Immunol Methods. 2007. PMID: 17512533 Free PMC article.

2

Enhancement of functional antibody responses to AMA1-C1/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide.

Mullen GE, Giersing BK, Ajose-Popoola O, Davis HL, Kothe C, Zhou H, Aebig J, Dobrescu G, Saul A, Long CA. Mullen GE, et al. Among authors: saul a. Vaccine. 2006 Mar 24;24(14):2497-505. doi: 10.1016/j.vaccine.2005.12.034. Epub 2006 Jan 4. Vaccine. 2006. PMID: 16434128

3

Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigen.

Mullen GE, Aebig JA, Dobrescu G, Rausch K, Lambert L, Long CA, Miles AP, Saul A. Mullen GE, et al. Among authors: saul a. Vaccine. 2007 Jul 20;25(29):5343-7. doi: 10.1016/j.vaccine.2007.05.007. Epub 2007 May 25. Vaccine. 2007. PMID: 17566616 Free PMC article.

4

Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders.

Qian F, Rausch KM, Muratova O, Zhou H, Song G, Diouf A, Lambert L, Narum DL, Wu Y, Saul A, Miller LH, Long CA, Mullen GE. Qian F, et al. Among authors: saul a. Vaccine. 2008 May 12;26(20):2521-7. doi: 10.1016/j.vaccine.2008.03.005. Epub 2008 Mar 27. Vaccine. 2008. PMID: 18423804 Free PMC article.

5

A quantitative slot blot assay for host cell protein impurities in recombinant proteins expressed in E. coli.

Zhu D, Saul AJ, Miles AP. Zhu D, et al. J Immunol Methods. 2005 Nov 30;306(1-2):40-50. doi: 10.1016/j.jim.2005.07.021. Epub 2005 Aug 18. J Immunol Methods. 2005. PMID: 16137696

6

Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer.

Zhu D, Huang S, McClellan H, Dai W, Syed NR, Gebregeorgis E, Rausch KM, Mullen GE, Long C, Martin LB, Narum D, Duffy P, Miller LH, Saul A. Zhu D, et al. Among authors: saul a. Vaccine. 2012 Jan 5;30(2):189-94. doi: 10.1016/j.vaccine.2011.11.025. Epub 2011 Nov 19. Vaccine. 2012. PMID: 22107848 Free PMC article.

7

Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations.

Miles AP, McClellan HA, Rausch KM, Zhu D, Whitmore MD, Singh S, Martin LB, Wu Y, Giersing BK, Stowers AW, Long CA, Saul A. Miles AP, et al. Among authors: saul a. Vaccine. 2005 Mar 31;23(19):2530-9. doi: 10.1016/j.vaccine.2004.08.049. Vaccine. 2005. PMID: 15752840

8

Determining residual host cell antigen levels in purified recombinant proteins by slot blot and scanning laser densitometry.

Miles AP, Zhu D, Saul A. Miles AP, et al. Among authors: saul a. Methods Mol Biol. 2005;308:233-42. doi: 10.1385/1-59259-922-2:233. Methods Mol Biol. 2005. PMID: 16082039 No abstract available.

9

Extraction and characterization of vaccine antigens from water-in-oil adjuvant formulations.

Miles AP, Saul A. Miles AP, et al. Among authors: saul a. Methods Mol Biol. 2005;308:293-300. doi: 10.1385/1-59259-922-2:293. Methods Mol Biol. 2005. PMID: 16082043 No abstract available.

10

Quantifying recombinant proteins and their degradation products using SDS-PAGE and scanning laser densitometry.

Miles AP, Saul A. Miles AP, et al. Among authors: saul a. Methods Mol Biol. 2005;308:349-56. doi: 10.1385/1-59259-922-2:349. Methods Mol Biol. 2005. PMID: 16082047 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

488 results

Search Page

Filters